- Pharmaceutical companies
- Santen Pharmaceutical
Santen Pharmaceutical
Phone: +81 81663217000
Fax: 81-6-6321-5082
| Native name | 参天製薬株式会社 |
|---|---|
| Type | Public KK |
| Traded as | TYO: 4536 OSE: 4536 |
| Industry | Pharmaceutical |
| Founded | Osaka, Japan (1890 (1890)) |
| Founder | Kenkichi Taguchi |
| Headquarters | Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka 530-8552, Japan |
| Key people | Akira Kurokawa, (CEO and President) |
| Products |
|
| Revenue | $ 2.429 billion (FY 2018) (¥ 243.0 billion) (FY 2018) |
| Net income | $ 175.661 million (FY 2012) (¥ 16.521 billion) (FY 2012) |
| Number of employees | 3,805(consolidated) (as of March 31, 2018) |
| Website | Official website |
As a specialized pharmaceutical company, Santen continues to make utmost efforts to contribute to ophthalmic treatment around the world.
For detailed contact information visit location pages below.
Santen Pharmaceutical's locations around the world
Europe
North America
Clinical Trials sponsored by Santen Pharmaceutical
-
Santen Pharmaceutical Co., Ltd.Rekruttering
-
Santen Pharmaceutical Co., Ltd.Fullført
-
Santen Pharmaceutical Co., Ltd.FullførtPrimær åpenvinkelglaukom, okulær hypertensjonJapan
-
Santen Pharmaceutical Co., Ltd.FullførtPrimær åpenvinkelglaukom eller okulær hypertensjonJapan
-
Santen Pharmaceutical Co., Ltd.FullførtFriske mannlige voksneJapan
-
Santen Pharmaceutical Co., Ltd.FullførtMakulaødem etter grenen retinal veneokklusjonJapan, Korea, Republikken
-
Santen Pharmaceutical Co., Ltd.FullførtOkulær hypertensjon | ÅpenvinkelglaukomJapan
-
Santen Pharmaceutical Co., Ltd.Aktiv, ikke rekrutterendeOkulær hypertensjon | Åpen vinkelglaukomKina
-
Santen Pharmaceutical Co., Ltd.FullførtÅpenvinkelglaukom, okulær hypertensjonJapan
-
Santen Pharmaceutical Co., Ltd.Fullført